All Curated Mutation Sites in HCV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HCV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
5'UTR
  
C
  
E1
  
E2
  
NS2
  
NS3
  
NS4B
  
NS5A
  
NS5B
  
p7
  
Protease
  

Keyword: HIV-HCV Coinfection-25940586
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 25940586 V36L
NS3
NS3
HIV-HCV Coinfection
D
G
R
S
L
View
2 25940586 I72N
NS3
NS3
HIV-HCV Coinfection
G
R
S
L
View
3 25940586 I72V
NS3
NS3
HIV-HCV Coinfection
G
R
S
L
View
4 25940586 Q80K
NS3
NS3
HIV-HCV Coinfection
D
G
R
S
L
View
5 25940586 I72T
NS3
NS3
HIV-HCV Coinfection
G
R
S
L
View
6 25940586 Q80G
NS3
NS3
HIV-HCV Coinfection
G
R
S
L
View
7 25940586 S122R
NS3
NS3
HIV-HCV Coinfection
G
R
S
L
View
8 25940586 V36P
NS3
NS3
HIV-HCV Coinfection
G
R
S
L
View
9 25940586 I170V
NS3
NS3
HIV-HCV Coinfection
G
R
S
L
View
10 25940586 D168Q
NS3
NS3
HIV-HCV Coinfection
G
R
S
L
View
11 25940586 S122T
NS3
NS3
HIV-HCV Coinfection
G
R
S
L
View
12 25940586 T54A
NS3
NS3
HIV-HCV Coinfection
D
G
R
S
L
View
13 25940586 I170L
NS3
NS3
HIV-HCV Coinfection
G
R
S
L
View
14 25940586 I72L
NS3
NS3
HIV-HCV Coinfection
G
R
S
L
View
Contents
Description

The table shows all curated mutation sites of HCV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.